The size of the blood flow measurement devices market in Europe was worth USD 139.09 million in 2023. This value is further expected to grow at a CAGR of 9.5% from 2023 to 2028 and be worth USD 218.96 million by 2028.
Blood flow measuring devices are essential in the diagnostic and research section of the healthcare industry. They aid clinicians in comprehending the nature of blood flow, such as aberrant variations in blood flow velocity and the volume of blood delivered to various essential organs, which may result in vascular malformation. Thus, blood flow measurement can give crucial data for precise diagnosis of illness. Furthermore, because of a non-invasive, fast, and reliable blood flow evaluation, early diagnosis and proper treatment of the condition will be achievable.
The growing demand for effective and early diagnosis drives the European blood flow measurement devices market. The growing patient population suffering from chronic diseases in Europe and the rapid adoption of technological developments are further propelling the European market growth. The blood flow measuring devices market can benefit from accessing a previously untapped sector and creating therapeutic applications for blood flow meters. Due to solid research and development operations, the demand for blood flow meters is consolidated, with certain prominent companies having the largest share. Manufacturers produce innovative products to exploit potential opportunities in the blood flow measuring devices market.
In addition, the growing prevalence of cardiovascular diseases and diabetes, the growing elderly population, technological improvements, and the influx of venture capital funding have contributed to the market growth.
However, the high cost of devices, stringent government regulations in developed countries, a scarcity of qualified personnel, and unfavorable reimbursement policies are critical limitations on the market for blood flow measurement devices.
This research report on the Europe blood flow measurement devices market has been segmented and sub-segmented into the following categories.
The Ultrasound segment is estimated to hold a major share of the European blood flow measurement devices market during the forecast period.
The CVDs segment is predicted to capture a major share of the European market during the forecast period.
Geographically, the European blood flow measuring devices market is expected to grow healthy during the forecast period. The blood flow measurement devices market in Europe is primarily driven by the availability of advanced treatment facilities, technological advancements in the healthcare sector, and favorable reimbursement policies. As a result, the major countries in the region, such as the United Kingdom, Germany, Spain, Italy, and France, significantly expanded the European blood flow monitoring equipment market.
The UK blood flow measurement devices market held the major share of the European market in 2022. The growth of the UK market is majorly driven by growing UK government assistance in developing the healthcare infrastructure and the growing demand for minimally invasive treatment. In addition, the rising use of these devices in cardiovascular disorders significantly impacts it. Every year, cardiovascular diseases account for more than 27% of all deaths in the United Kingdom.
On the other hand, the German blood flow measurement devices market is anticipated to witness a prominent share during the forecast period owing to the increased prevalence of diabetes, growing the demand for blood flow measurement devices in Germany favorably. Furthermore, the European market is flooded with novel items like contactless diagnosis and wearable monitoring gadgets, likely to drive even more significant revenue development in the region.
KEY MARKET PLAYERS:
Companies playing a notable role in the Europe blood flow measurements devices market profiled in the report are Compumedics Ltd. (Australia), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Perimed AB (Sweden), Medistim ASA (Norway), ADInstruments (Australia), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), SONOTEC Ultraschallsensorik Halle GmbH (Germany), and Moor Instruments Ltd. (U.K.).
The Europe blood flow measurement devices market is anticipated to grow at a CAGR of 9.5% from 2023 to 2028.
The growing prevalence of cardiovascular diseases, technological advancements in blood flow measurement devices, and rising demand for non-invasive diagnostic procedures are propelling the blood flow measurement devices market in Europe.
Medistim ASA, Deltex Medical Group plc, Moor Instruments Ltd., and Transonic Systems Inc. are some of the noteworthy companies in the European blood flow measurement devices market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com